AI Nutrition Pioneer Nuvilab Fuels North American Expansion with New Funding
March 31, 2026, 4:18 pm
Nuvilab, an AI nutrition analytics innovator, secures Series A bridge funding from NAVER D2SF. This crucial investment accelerates its ambitious expansion into the North American healthcare market. Nuvilab’s cutting-edge, image-based AI solution meticulously analyzes food type, intake, and nutritional content. It delivers 98% accuracy in 0.3 seconds. The technology streamlines hospital operations, reducing errors by 49% and cutting food preparation time by 23%. With over 1,000 global clients and 100,000 users, Nuvilab is set to redefine dietary management. The company plans deeper integrations with insurers and pharmaceuticals, structuring vital nutrition data for clinical and operational excellence across the US.
Nuvilab, a leader in AI nutrition analytics, has secured significant Series A bridge funding. NAVER D2SF, a venture arm of tech giant NAVER, made a follow-on investment. This capital injection targets aggressive expansion into the North American healthcare sector. The move solidifies Nuvilab’s position as a rising force in health technology.
The company’s core innovation is an AI-powered nutrition management solution. It utilizes image-based scanning. This system analyzes food type, intake, and nutritional content in real time. It offers a powerful tool for dietary tracking.
Nuvilab’s technology deploys across diverse environments. Hospitals, schools, and daycare centers use it. The system facilitates passive and continuous data collection. It eliminates manual input, a common industry bottleneck. This efficiency drives its strong adoption rates.
A multimodal AI model underpins Nuvilab’s platform. This model is robust. It trained on over 100 million food data points. Such extensive training ensures high performance. The AI boasts 98% accuracy. It processes data within a rapid 0.3 seconds. This speed and precision set it apart.
The solution has demonstrated impressive user engagement. It achieved a 95% retention rate. This figure significantly exceeds typical healthcare industry benchmarks. High retention underscores user satisfaction and value.
Nuvilab first established strong market validation in Korea. It excelled in B2B and B2G markets there. Its proven track record provides a solid foundation. Now, Nuvilab brings its expertise to North America. The expansion focuses particularly on the United States.
As of late 2025, Nuvilab reported substantial global traction. The company serves over 1,000 global clients. It supports 100,000 active users. This scale highlights its broad market acceptance.
A strategic partnership accelerates its US growth. Nuvilab secured an exclusive agreement with one of the world's largest catering groups. This partnership facilitates deployment across US hospitals. It ensures widespread implementation.
Nuvilab’s technology delivers measurable operational improvements in hospital settings. A proof-of-concept study revealed significant gains. The platform automates patient meal verification. It matches meal tickets with actual meals served. This process was once prone to error.
The AI solution reduced errors by 49%. This nearly halves costly mistakes. It also shortened food preparation time by 23%. Such efficiencies are critical for busy healthcare facilities. They optimize resource allocation.
Beyond operational benefits, Nuvilab aims for broader impact. It plans to expand into comprehensive healthcare applications. Dietary intake analytics represent a key area. The platform will provide deeper insights into patient nutrition.
Further integrations are on the horizon. Nuvilab seeks connections with insurers. It also targets pharmaceutical companies. This vision involves structuring and utilizing nutrition data. It aims to embed this data within clinical and operational workflows. Such integration could revolutionize personalized healthcare.
Dietary habits often remain unstructured. Their potential in healthcare is largely untapped. Nuvilab addresses this fundamental challenge. It structures dietary data through advanced AI. This approach creates new avenues for health management.
NAVER D2SF’s continued investment signals strong confidence. They first provided seed backing in 2021. This follow-on investment reflects Nuvilab’s growth trajectory. It acknowledges the company’s commercial traction. NAVER D2SF supports startups pushing global boundaries.
The demand for innovative healthcare technology is growing. AI nutrition solutions offer a critical advantage. They enhance patient care productivity. They streamline complex dietary management. Nuvilab stands at the forefront of this evolution.
The company is refining its solution for North American hospitals. It prioritizes patient care enhancements. Rapid customer base expansion is a key objective. Nuvilab anticipates sustained growth in the US market.
Its technology fundamentally reshapes healthcare. It transforms how nutrition data is collected. It changes how it is analyzed and utilized. This intelligent approach defines a new category. Nuvilab aims to lead this global shift. Its journey reflects a commitment to innovation. It promises a healthier future powered by data.
Nuvilab, a leader in AI nutrition analytics, has secured significant Series A bridge funding. NAVER D2SF, a venture arm of tech giant NAVER, made a follow-on investment. This capital injection targets aggressive expansion into the North American healthcare sector. The move solidifies Nuvilab’s position as a rising force in health technology.
The company’s core innovation is an AI-powered nutrition management solution. It utilizes image-based scanning. This system analyzes food type, intake, and nutritional content in real time. It offers a powerful tool for dietary tracking.
Nuvilab’s technology deploys across diverse environments. Hospitals, schools, and daycare centers use it. The system facilitates passive and continuous data collection. It eliminates manual input, a common industry bottleneck. This efficiency drives its strong adoption rates.
A multimodal AI model underpins Nuvilab’s platform. This model is robust. It trained on over 100 million food data points. Such extensive training ensures high performance. The AI boasts 98% accuracy. It processes data within a rapid 0.3 seconds. This speed and precision set it apart.
The solution has demonstrated impressive user engagement. It achieved a 95% retention rate. This figure significantly exceeds typical healthcare industry benchmarks. High retention underscores user satisfaction and value.
Nuvilab first established strong market validation in Korea. It excelled in B2B and B2G markets there. Its proven track record provides a solid foundation. Now, Nuvilab brings its expertise to North America. The expansion focuses particularly on the United States.
As of late 2025, Nuvilab reported substantial global traction. The company serves over 1,000 global clients. It supports 100,000 active users. This scale highlights its broad market acceptance.
A strategic partnership accelerates its US growth. Nuvilab secured an exclusive agreement with one of the world's largest catering groups. This partnership facilitates deployment across US hospitals. It ensures widespread implementation.
Nuvilab’s technology delivers measurable operational improvements in hospital settings. A proof-of-concept study revealed significant gains. The platform automates patient meal verification. It matches meal tickets with actual meals served. This process was once prone to error.
The AI solution reduced errors by 49%. This nearly halves costly mistakes. It also shortened food preparation time by 23%. Such efficiencies are critical for busy healthcare facilities. They optimize resource allocation.
Beyond operational benefits, Nuvilab aims for broader impact. It plans to expand into comprehensive healthcare applications. Dietary intake analytics represent a key area. The platform will provide deeper insights into patient nutrition.
Further integrations are on the horizon. Nuvilab seeks connections with insurers. It also targets pharmaceutical companies. This vision involves structuring and utilizing nutrition data. It aims to embed this data within clinical and operational workflows. Such integration could revolutionize personalized healthcare.
Dietary habits often remain unstructured. Their potential in healthcare is largely untapped. Nuvilab addresses this fundamental challenge. It structures dietary data through advanced AI. This approach creates new avenues for health management.
NAVER D2SF’s continued investment signals strong confidence. They first provided seed backing in 2021. This follow-on investment reflects Nuvilab’s growth trajectory. It acknowledges the company’s commercial traction. NAVER D2SF supports startups pushing global boundaries.
The demand for innovative healthcare technology is growing. AI nutrition solutions offer a critical advantage. They enhance patient care productivity. They streamline complex dietary management. Nuvilab stands at the forefront of this evolution.
The company is refining its solution for North American hospitals. It prioritizes patient care enhancements. Rapid customer base expansion is a key objective. Nuvilab anticipates sustained growth in the US market.
Its technology fundamentally reshapes healthcare. It transforms how nutrition data is collected. It changes how it is analyzed and utilized. This intelligent approach defines a new category. Nuvilab aims to lead this global shift. Its journey reflects a commitment to innovation. It promises a healthier future powered by data.